Long-Term Effects of COVID-19 on Neurological Health
Study reveals lasting impacts of COVID-19 on patients with neurological issues.
― 5 min read
Table of Contents
COVID-19 has affected many parts of the body, including the brain. Some patients have experienced serious neurological issues like strokes, seizures, and other brain problems. This article looks at what happened to these patients over three years after their COVID-19 Hospital Stays compared to those who did not have significant neurological issues.
Background
When patients get COVID-19, they can have different Health Problems. Some studies show that the virus might affect the brain directly, while others think it mostly causes indirect issues through other health problems. Patients with brain issues during COVID-19 often have a harder time recovering than those without.
The main goal of this study was to see how patients with neurological problems after COVID-19 did over a three-year follow-up period compared to similar patients who did not have these issues. By better understanding these outcomes, we can help identify patients who may need more support after they leave the hospital.
Study Design
This research followed strict guidelines to ensure it was done properly. It looked back at past data from patients who were admitted to a hospital system because of COVID-19. They were confirmed to have the virus through testing. The follow-up lasted three years after their hospital stay.
The study included patients who had significant neurological issues and required brain scans during their hospital stay. There were a total of 636 patients in this group. The control group, which consisted of 1,743 patients who did not have major neurological issues, was matched by age and severity of COVID-19 illness.
After some patients were removed from the study due to various reasons, the final group included 414 patients with neurological issues and 1,199 without.
Data Collection
Information was collected from electronic medical records. Health data were stored in a standard format to analyze different types of data effectively. The data included demographic information, medical history, and lab test results. The conditions of patients at discharge were also recorded, including where they went after leaving the hospital, such as returning home or going to a rehabilitation center.
Patient Outcomes
The main focus was on what happened to patients three years after being treated for COVID-19. The outcomes measured included whether they experienced a stroke, heart attack, or other serious health events after leaving the hospital. Their chances of being readmitted to the hospital were also tracked.
Patients with neurological problems had higher rates of complications. For instance, they had more strokes and heart issues than those without significant neurological complaints. Mortality Rates were also higher in the neurological group at various time points after discharge, indicating that these patients faced more serious challenges in recovery.
Hospital Discharge
When patients were ready to leave the hospital, their discharge plans varied based on their health. Those with severe COVID-19 illness were less likely to go home and more likely to go to places like skilled nursing facilities or hospice care. This was true for both groups of patients, but the neurological group had higher rates of being placed in nursing facilities and fewer were discharged home compared to controls.
Survival Rates
Survival analysis showed that patients with neurological issues had a lower chance of surviving after discharge. This was confirmed by statistical analysis that indicated those with neurological problems had a higher risk of dying after leaving the hospital.
Causes of Death
When looking at the reasons for death among patients post-COVID-19, the primary causes were similar for both groups. Heart disease, infections, and respiratory issues were common. A significant number of deaths had an unknown cause, suggesting that some patients may have died from general age-related issues or unrecorded health problems.
Comparing Survivors and Non-Survivors
Among both groups, those who did not survive after discharge were often older and had more severe cases of COVID-19. The non-survivors also had a higher rate of comorbid conditions, meaning other health problems that could complicate their recovery.
Risk Factors for Poor Outcomes
Several factors were linked to higher chances of dying after discharge. Being in the neurological group was a key risk factor. Other important factors included where patients were discharged (like to nursing homes), heart failure, severity of COVID-19, and age. Male patients also tended to have worse outcomes, though this was less clear.
Imaging Results
Patients underwent imaging studies like CT scans and MRIs before, during, and after their hospitalization. These imaging studies aimed to check for changes in the brain related to their COVID-19 infection. Doctors looked for signs of stroke, bleeding, and other abnormalities.
Results showed that many patients experienced some issues with their brains due to age-related effects. The neurological group showed a higher degree of certain abnormalities than the control group.
Importance of This Study
This study sheds light on the long-term effects of COVID-19, especially on patients with significant neurological problems. Many patients in both groups were not independent after leaving the hospital, needing ongoing care and support.
Understanding these long-term outcomes helps healthcare providers better prepare for the needs of COVID-19 survivors, particularly those with neurological issues. Future efforts should focus on providing the right resources and screening for at-risk patients to reduce the burden of care and improve overall outcomes.
Limitations
While this research provides valuable insights, it has limitations. The patient group was primarily from the early days of the pandemic, when treatments and understanding of COVID-19 were limited. Also, the data was gathered retrospectively, which could introduce biases. Additionally, some patients who did not return for follow-up could have had different experiences that were not captured in this study.
Conclusion
Patients who had significant neurological concerns during COVID-19 hospitalization faced more challenges in their recovery compared to those who did not. These findings highlight the need for ongoing support and research into the lasting impacts of COVID-19 on overall health and well-being. Better screening and interventions can potentially help manage the care load for patients affected by COVID-19 in the future.
Title: Long-term outcomes of hospitalized SARS-CoV-2/COVID-19 patients with and without neurological involvement: 3-year follow-up assessment
Abstract: Background and ObjectivesAcute neurological manifestations are a common complication of acute COVID-19 disease. This study investigated the 3-year outcomes of patients with and without significant neurological manifestations during initial COVID-19 hospitalization. MethodsPatients infected by SARS-CoV-2 between March 1 and April 16, 2020 and hospitalized in the Montefiore Health System in the Bronx, an epicenter of the early pandemic, were included. Follow-up data was captured up to January 23, 2023 (3 years post COVID-19). This cohort consisted of 414 COVID-19 patients with significant neurological manifestations and 1199 propensity-matched COVID- 19 patients without neurological manifestations. Primary outcomes were mortality, stroke, heart attack, major adverse cardiovascular events (MACE), reinfection, and hospital readmission post-discharge. Secondary outcomes were clinical neuroimaging findings (hemorrhage, active stroke, prior stroke, mass effect, and microhemorrhage, white-matter changes, microvascular disease, and volume loss). Predictive models were used to identify risk factors of mortality post-discharge. ResultsMore patients in the neurological cohort were discharged to acute rehabilitation (10.54% vs 3.68%, p
Authors: Tim Q Duong, A. Eligulashvili, M. Gordon, J. S. Lee, J. Lee, S. Mehrotra-Varma, J. Mehrotra-Varma, K. Hsu, I. Hilliard, K. Lee, A. Li, M. A. Essibayi, J. Yee, D. J. Altschul, E. Eskandar, M. F. Mehler
Last Update: 2023-06-29 00:00:00
Language: English
Source URL: https://www.medrxiv.org/content/10.1101/2023.06.26.23291883
Source PDF: https://www.medrxiv.org/content/10.1101/2023.06.26.23291883.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to medrxiv for use of its open access interoperability.